| Product NDC: | 51672-1338 |
| Proprietary Name: | Flo-Pred |
| Non Proprietary Name: | Prednisolone Acetate |
| Active Ingredient(s): | 15 mg/5mL & nbsp; Prednisolone Acetate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51672-1338 |
| Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022067 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080117 |
| Package NDC: | 51672-1338-5 |
| Package Description: | 1 BOTTLE in 1 CARTON (51672-1338-5) > 37 mL in 1 BOTTLE |
| NDC Code | 51672-1338-5 |
| Proprietary Name | Flo-Pred |
| Package Description | 1 BOTTLE in 1 CARTON (51672-1338-5) > 37 mL in 1 BOTTLE |
| Product NDC | 51672-1338 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Prednisolone Acetate |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20080117 |
| Marketing Category Name | NDA |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Substance Name | PREDNISOLONE ACETATE |
| Strength Number | 15 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |